Fixed-time treatment of elderly patients with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) using hypomethylating agents and venetoclax – a case series
Abstract Standard therapy for elderly patients with acute myeloid leukemia (AML) consists of hypomethylating agents (HMAs) combined with venetoclax (VEN), administered long term until disease progression. However, several retrospective studies have shown that patients in complete remission (CR) who...
Zapisane w:
| Główni autorzy: | , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Springer
2026-05-01
|
| Seria: | Annals of Hematology |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1007/s00277-026-07076-z |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|